PRODIGY BIOTECH

EUIPO EUIPO 2023 Application opposed

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark PRODIGY BIOTECH was filed as Word mark on 10/20/2023 at the European Union Intellectual Property Office. The current status of the mark is "Application opposed".

Trademark Details Last update: June 6, 2024

Trademark form Word mark
File reference 018940116
Application date October 20, 2023
Publication date December 7, 2023

Trademark owner

719 Bradford Terrace
19382 West Chester,
US

Trademark representatives

Avenida México 20 03008 Alicante ES

Objection / Complaint

02/21/2024: Likelihood of confusion
Applicant
TRICHODEX, S.L.U.

goods and services

5 Pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutics and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product, namely, antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of gut dysbioses, inflammatory disorders and conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, and digestive abnormalities; pharmaceutical and therapeutic preparations for use in the prevention and treatment of abnormalities in the human gut microbiome and gastrointestinal health; pharmaceutical preparations for medical, veterinary and aquaculture purposes, namely, antibacterial treatments, anti-toxin treatments, antibiotic treatments and antiviral treatments

ID: 11018940116